Disagreement FDA and EMA on RSV Maternal Vaccination: Possible Consequence for Global Mortality

The Pediatric infectious disease journal(2024)

引用 0|浏览6
暂无评分
摘要
The European Medicines Agency and the US Food and Drug Administration have recently approved a maternal vaccine for respiratory syncytial virus. The US Food and Drug Administration limits vaccination to later in pregnancy. Mathematical modeling demonstrates that this vaccination window may reduce the global mortality impact of the vaccine by 12%. Policymakers should carefully consider vaccine risks and benefits to safeguard vulnerable infants effectively.
更多
查看译文
关键词
maternal vaccination,RSV,vaccine recommendations,vaccine administration timing,EMA guidelines,FDA guidelines,infant mortality,LMICs,vaccine licensure,Abrysvo vaccine,vaccine impact
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要